303 related articles for article (PubMed ID: 12015517)
1. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
[TBL] [Abstract][Full Text] [Related]
3. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
[TBL] [Abstract][Full Text] [Related]
4. Adherence to oral therapies in pelvic inflammatory disease.
Dunbar-Jacob J; Sereika SM; Foley SM; Bass DC; Ness RB
J Womens Health (Larchmt); 2004 Apr; 13(3):285-91. PubMed ID: 15130257
[TBL] [Abstract][Full Text] [Related]
5. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.
Haggerty CL; Totten PA; Astete SG; Lee S; Hoferka SL; Kelsey SF; Ness RB
Sex Transm Infect; 2008 Oct; 84(5):338-42. PubMed ID: 18445635
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.
Sweet RL; Schachter J; Landers DV; Ohm-Smith M; Robbie MO
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):736-41. PubMed ID: 3162653
[TBL] [Abstract][Full Text] [Related]
7. Outpatient treatment of pelvic inflammatory disease with cefoxitin and doxycycline.
Wølner-Hanssen P; Paavonen J; Kiviat N; Young M; Eschenbach DA; Holmes KK
Obstet Gynecol; 1988 Apr; 71(4):595-600. PubMed ID: 3353051
[TBL] [Abstract][Full Text] [Related]
8. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.
Haggerty CL; Ness RB; Amortegui A; Hendrix SL; Hillier SL; Holley RL; Peipert J; Randall H; Sondheimer SJ; Soper DE; Sweet RL; Trucco G
Am J Obstet Gynecol; 2003 Jan; 188(1):141-8. PubMed ID: 12548208
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
[TBL] [Abstract][Full Text] [Related]
10. Design of the PID Evaluation and Clinical Health (PEACH) Study.
Ness RB; Soper DE; Peipert J; Sondheimer SJ; Holley RL; Sweet RL; Hemsell DL; Randall H; Hendrix SL; Bass DC; Kelsey SF; Songer TJ; Lave JR
Control Clin Trials; 1998 Oct; 19(5):499-514. PubMed ID: 9741869
[TBL] [Abstract][Full Text] [Related]
11. Outpatient pelvic inflammatory disease treatment as effective as inpatient care, study finds.
Levenson D
Rep Med Guidel Outcomes Res; 2002 Jun; 13(11):9-10, 12. PubMed ID: 12498174
[No Abstract] [Full Text] [Related]
12. Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?
Trautmann GM; Kip KE; Richter HE; Soper DE; Peipert JF; Nelson DB; Trout W; Schubeck D; Bass DC; Ness RB
Am J Obstet Gynecol; 2008 Jan; 198(1):30.e1-7. PubMed ID: 18166300
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease.
Walters MD; Gibbs RS
Obstet Gynecol; 1990 May; 75(5):867-72. PubMed ID: 2183112
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group.
Acta Obstet Gynecol Scand; 1992 Feb; 71(2):129-34. PubMed ID: 1316041
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.
Roy S; Koltun W; Chatwani A; Martens MG; Dittrich R; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):67S-73S. PubMed ID: 9935260
[TBL] [Abstract][Full Text] [Related]
16. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.
Trent M; Bass D; Ness RB; Haggerty C
Sex Transm Dis; 2011 Sep; 38(9):879-81. PubMed ID: 21844746
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.
Hemsell DL; Little BB; Faro S; Sweet RL; Ledger WJ; Berkeley AS; Eschenbach DA; Wölner-Hanssen P; Pastorek JG
Clin Infect Dis; 1994 Oct; 19(4):720-7. PubMed ID: 7803638
[TBL] [Abstract][Full Text] [Related]
18. GPs should be vigilant for pelvic inflammatory disease.
Soleymani majd H; Ismail L; Currie I
Practitioner; 2011 Mar; 255(1738):15-8, 2. PubMed ID: 21510504
[TBL] [Abstract][Full Text] [Related]
19. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.
Savaris RF; Teixeira LM; Torres TG; Edelweiss MI; Moncada J; Schachter J
Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896
[TBL] [Abstract][Full Text] [Related]
20. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
Piyadigamage A; Wilson J
Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
